This Week in Nature

In Nature this week, researchers from the University of Bonn and the University of California, Los Angeles, describe the use of a genetically engineered mouse to how melanomas become resistant to treatment. Adoptive cell therapies, which fight tumors with cytotoxic T cells, are often initially effective in treating melanoma, but patients frequently relapse.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.